Advanced Search

 

Study ID Status Title Patient Level Data
FLTB3017 Completed A multi-centre, randomised, double-blind, placebo-controlled parallel group study to determine the efficacy and safety of inhaled fluticasone propionate 100mg bd and 250mg bd delivered via the Babyhaler™ spacer device in the management of asthma symptoms in children aged 12–47 months inclusive.
FLTB3021 Completed A double-blind, double-dummy, randomised, parallel group study to evaluate the early substitution of nebulised fluticasone propionate (FP) 2mg twice daily (bd) for oral prednisolone 50mg once daily (od) during the early recovery period after an acute exacerbation of asthma in adult patients.
FLTB3026 Completed A single centre, randomised, double-blind, cross-over study to determine the effects of fluticasone propionate (Flixotidea) 500µg BD delivered via the MDI and spacer compared with placebo on the cellular and cytokine characteristics of induced sputum in subjects with COPD.
FLTB3030 Completed A phase III, multi-centre, double-blind, randomised, cross-over group study to evaluate the efficacy and safety of fluticasone propionate Nebules 0.5mg twice daily compared with placebo in the treatment of symptomatic asthma in children under 4 years of age.
FLTB3031 Completed A randomised, double-blind, parallel-group clinical trial to establish the safety and efficacy of nebulised fluticasone propionate 1mg twice daily compared with oral prednisolone administered for 7 days to pre-school children aged 48 months or less with an acute exacerbation of asthma.
FLTB3036 Completed A single-centre, randomised, double-blind, parallel group study to investigate the effects of high-dose inhaled corticosteroid therapy on bone mass in adult patients with moderately severe asthma
FLTB3038 Completed A study to investigate the effectiveness of fluticasone propionate (FP) 200 mg/day versus beclomethasone dipropionate (BDP) 400 mg/day delivered via the Babyhaler™ spacer device in patients with a history of wheeze aged 2 to 18 months.
FLTB3039 Completed A multi-centre, randomised, double-blind, parallel group study of the efficacy and safety of inhaled fluticasone propionate 1000mg daily with placebo in chronic obstructive pulmonary disease
FLTB3040 Completed A single-centre, double-blind, double dummy, randomised cross-over study to compare the effectiveness of fluticasone propionate (FP), oral prednisolone and placebo in the prevention of viral-induced asthma in children.
FLTB3044 Completed A single centre double blind, double dummy cross-over study to investigate urinary cortisol metabolites, bone metabolism markers and growth in asthmatic children treated with inhaled steroids.
FLTB3047 Completed A Multi-centre, Randomised, Double Blind, Parallel Group Clinical Trial to Assess the Efficacy and Tolerability of Fluticasone Propionate/GR106642X 100mcg bd Compared with Fluticasone Propionate/Propellants 11 and 12 100mcg bd Administered by Pressurised Metered-Dose Inhaler in Paediatric Patien ...
FLTB3048 Completed A Multi-Centre, Randomised, Double-Blind Parallel Group Clinical Trial to Assess the Long-Term (52 Weeks) Safety of Fluticasone Propionate 500mcg BD Administered by Pressurised Metered Dose Inhaler Propelled by GR106642X Propellant in Comparison with Propellants 11 and 12 in Adolescent and Adult ...
FLTB3049 Completed A phase III, randomised, double-blind, parallel group study to compare the efficacy of inhaled fluticasone propionate 100mg given once daily and fluticasone propionate 50mg given twice daily, both delivered via the multi-dose powder inhaler, in children aged 4–16 years with mild to…
FLTB3051 Completed Report on a multicentre, randomised, double-blind, parallel-group clinical trial to compare the efficacy and safety of the dry powder formulation of fluticasone proprionate (FP) 200mg/day with fluticasone proprionate 400mg/day administered for 6 weeks from a multidose powder device (Diskus™) to…
FLTB3052 Completed A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel Group Study Examining the Effect of Fluticasone Propionate Aqueous Nasal Spray (200µg once daily (od)) as an Adjunct to Antibiotic Therapy in Subjects with Recurrent Sinusitis.
FLTB3053 Completed A multicentre, randomised, double-blind, placebo-controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200µg once daily [od]) as an adjunct to antibiotic therapy in subjects with recurrent sinusitis.
FLTB3054 Completed A multicentre, double-blind, placebo-controlled, parallel group study of the efficacy and tolerability of long-term inhaled fluticasone propionate 500mg twice daily via a Volumatic Spacer device in patients with non-asthmatic chronic obstructive pulmonary disease, including… Study Listed on ClinicalStudyDataRequest.com
FLTB3055 Completed A double blind, double dummy, crossover study to compare the systemic pharmacodynamic effects and safety of inhaled fluticasone propionate Nebules™ 1mg bd with oral prednisolone administered for 7 days to children aged 4 to 16 years with asthma.
FLTB4002 Completed A single centre, randomised, open cross-over study to compare the handling and efficacy of fluticasone propionate 50mcg bd delivered via multi-dose powder inhaler (MDPI) or via Diskhaler in paediatric patients with asthma
FLTB4003 Completed A comparison of the efficacy and tolerability of high dose inhaled fluticasone propionate via a metered-dose inhaler and the Volumatic spacer device with nebulised budesonide in adult asthmatics.
FLTB4009 Completed A Study to Determine the Systemic Activity of a Single Dose of Fluticasone Propionate via the Diskus in Asthmatic Children Inhaling at Different Inspiratory Flows
FLTF3003 Completed A multicentre, randomised, double-blind, parallel group, controlled versus placebo, eight month study, to evaluate efficacy and tolerability of fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis in adults.
Flu-Pan-Meta-Analysis-201109 Completed Integrated summary of the safety of AS03-adjuvanted monovalent H5N1 and H1N1 vaccines in adults 18 years of age and older
FLUPD/AH90/N081 Completed A phase III multicentre, open, parallel-group, randomised study to compare the efficacy and tolerability of fluticasone propionate 50 micrograms bd via the Diskhaler™ with inhaled sodium cromoglycate (Intal) 20 milligrams qds via the Spinhaler in asthmatic children with a clinic requirement for ...
FLUTI/AH89/J78 Completed A phase III, multi-centre, open-label, parallel group study to compare the efficacy and tolerability of fluticasone propionate 500 micrograms bd with budesonide 600 micrograms bd administered via a metered dose inhaler in adult patients with moderate to severe symptomatic asthma.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.